Huadong Medicine (000963) Stock Price, Fundamentals & Analysis

What 000963 does

Huadong Medicine (000963) is a stock listed on the Shenzhen Stock Exchange in the Healthcare sector, specifically in the Drug Manufacturers - Specialty & Generic industry. The company, headquartered in Hangzhou, China, engages in the wholesale and retail of pharmaceutical products in China and internationally. It operates through Pharmaceutical Manufacturing, Pharmaceutical Distribution, Medical Aesthetics, and Industrial Microbiology segments, offering Chinese medicine, immunosuppressive agents, endocrine, digestive system, antineoplastic, cardiovascular, antibiotic drugs, medical beauty products, and medical devices, as well as pharmaceutical logistics and industrial microbiology services. Huadong Medicine also provides formulation filling, technical, transportation, and warehousing services. The company has a strategic collaboration with Heidelberg Pharma AG to jointly develop Antibody Drug Conjugates (ADCs). It is part of the Shenzhen Stock Exchange stocks universe and has peers such as Chongqing Zhifei Biological Products (300122), Hangzhou Tigermed Consulting (300347), Mindray (300760), IMEIK TECHNOLOGY DEVELOPMENT (300896), Pharmaron Beijing (300759), China Resources Sanjiu Medical & Pharmaceutical (000999), and Shijiazhuang Yiling Pharmaceutical (002603).

Key numbers explained

• The current price is 26.06 CNY, which represents the latest trading price of one share.
• The trailing P/E ratio of 13.2 divides the current share price by the last twelve months of earnings per share (1.98 CNY), showing how much investors pay per unit of recent earnings.
• The forward P/E ratio of 10.4 uses expected future earnings, offering a view of valuation based on analyst estimates.
• The dividend yield of 3.57% indicates the annual dividend as a percentage of the current share price; the ex-dividend date is 18 sept. 2026.
• The company pays out 47% of its earnings as dividends, meaning roughly half of the profit is returned to shareholders.
• Beta of 0.01 suggests the stock's price movements have historically been very low relative to the overall market.
• The 52-week price range is 25,63 – 43,78 CNY, with the current price near the lower end of that range; the price change over the last 52 weeks is -36.4%.
• Market capitalization of 45.7 mld. CNY reflects the total market value of all outstanding shares.

What to watch

Investors tracking Huadong Medicine (000963) may monitor factors common to healthcare and pharmaceutical stocks. Revenue growth, here at -0.5% year over year, and profit margins, at 7.9%, are standard indicators of top-line and bottom-line performance. Operating margin of 9.4% and return on equity of 13.8% provide insight into operational efficiency and shareholder capital usage. The debt-to-equity ratio of 8.6% is a measure of financial leverage, while price-to-book of 1.8 compares the market price to the company's book value. For a stock in this sector, pipeline developments, regulatory approvals, and collaboration agreements (such as the one with Heidelberg Pharma AG) can influence sentiment. The company's position within the broader Shenzhen Stock Exchange ecosystem and its relationship with peers in the Drug Manufacturers - Specialty & Generic space are also relevant context for portfolio tracking.